Disease burden of patients with pemphigus from a societal perspective. (2nd January 2021)
- Record Type:
- Journal Article
- Title:
- Disease burden of patients with pemphigus from a societal perspective. (2nd January 2021)
- Main Title:
- Disease burden of patients with pemphigus from a societal perspective
- Authors:
- Brodszky, V.
Tamási, B.
Hajdu, K.
Péntek, M.
Szegedi, A.
Sárdy, M.
Bata-Csörgő, Z.
Kinyó, Á.
Gulácsi, L.
Rencz, F. - Abstract:
- ABSTRACT: Introduction : Cost-of-illness studies are widely used for healthcare decision-making; however, no such study is available in pemphigus from the societal perspective. The purpose of this analysis was to estimate annual cost-of-illness per patient with pemphigus from a societal perspective. Areas covered : Between 2014 and 2017, a multicenter, cross-sectional study was carried out. Consecutive pemphigus patients aged ≥18 years were recruited at all four university dermatology departments in Hungary. Direct and indirect costs were calculated, including costs for treatments, outpatient visits, hospital admissions, informal care, travel costs and productivity loss. Generalized linear model was used to analyze predictors of costs. Atotal of 109 patients with pemphigus enrolled with amean age of 57.1 (SD 14.8) years. Total cost per pemphigus patient was €3, 995 (SD €7, 526) peryear, with productivity loss (58%) and informal care (19%) accounting for the majority. Annual means of 189 and 41 working hours were lost due to absence from work and reduced productivity, respectively. Younger age and pemphigus vulgaris were associated with higher costs (p < 0.05). Expert opinion : This is the first cost-of-illness study applying the societal perspective in pemphigus. Our results indicate a substantial economic burden on society, mainly driven by productivity loss and informal care.
- Is Part Of:
- Expert review of pharmacoeconomics & outcomes research. Volume 21:Number 1(2021)
- Journal:
- Expert review of pharmacoeconomics & outcomes research
- Issue:
- Volume 21:Number 1(2021)
- Issue Display:
- Volume 21, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 21
- Issue:
- 1
- Issue Sort Value:
- 2021-0021-0001-0000
- Page Start:
- 77
- Page End:
- 86
- Publication Date:
- 2021-01-02
- Subjects:
- Pemphigus vulgaris -- pemphigus foliaceus -- cost-of-illness -- cost analysis -- absenteeism -- presenteeism
Pharmacology -- Economic aspects -- Periodicals
338.47615105 - Journal URLs:
- http://www.future-drugs.com/loi/erp ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/14737167.2020.1722104 ↗
- Languages:
- English
- ISSNs:
- 1473-7167
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002996
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 22650.xml